Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Chenguang Biotech Group
300138
5
Shanghai Menon Animal Nutrition Technology
301156
CN Stock MarketDetailed Quotes
601939 China Construction Bank Corporation
- 8.74
- -0.14-1.58%
Trading Apr 8 09:41 CST
2.19TMarket Cap6.51P/E (TTM)
8.83High8.70Low264.29KlotVolume8.80Open8.88Pre Close231.46MTurnover0.28%Turnover Ratio6.51P/E (Static)250.01BShares8.9952wk High0.69P/B83.85BFloat Cap6.4052wk Low9.77Limit Up9.59BShs Float8.99Historical High7.99Limit Down1.46%Amplitude-1.36Historical Low0.60Dividend TTM8.76Avg Price128.01KlotAsk6.83%Div YieldTTM100Lot Size114.55KlotBid
China Construction Bank Corporation Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net deposit increase | -63.25%1.02T | -15.23%2.21T | -49.41%1.65T | -20.24%1.88T | -12.07%2.77T | -14.56%2.61T | 27.62%3.27T | 59.60%2.35T | 84.93%3.16T | 68.43%3.05T |
| Net increase in borrowings from central bank | ---- | ---- | ---- | ---- | 336.26%376.76B | 384.50%149.06B | 30.30%111.16B | 7.61%42.71B | --86.36B | --30.77B |
| Cash received from interests, fees and commissions | -1.44%1.13T | -1.83%843.56B | -0.73%569.01B | 3.19%298.38B | 4.73%1.14T | 6.58%859.3B | 7.10%573.2B | 7.18%289.16B | 7.75%1.09T | 7.49%806.22B |
| Net increase in repurchase business capital | --503.57B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --207.14B | --39.36B |
| Net increase in funds disbursed | 89.70%64.67B | -74.01%26.23B | 2.71%65.85B | -78.31%14.69B | -17.66%34.09B | 194.03%100.92B | -8.75%64.12B | -18.92%67.74B | --41.41B | 113.71%34.32B |
| Cash received relating to other operating activities | 9.65%362.88B | -38.36%194.22B | 118.87%149.03B | 405.94%120.86B | 16.77%330.95B | 172.60%315.06B | -22.17%68.09B | -42.83%23.89B | 127.67%283.41B | 104.19%115.58B |
| Special items of operating cash inflws | 44.76%306.66B | 12,211.17%321.94B | 150.00%282.95B | ---- | -0.62%211.84B | -99.02%2.62B | -56.34%113.18B | 94.96%15.46B | -19.81%213.15B | 175.12%265.89B |
| Cash inflows from operating activities | -20.14%3.95T | -3.38%4.13T | -30.99%2.91T | -10.06%2.51T | -3.95%4.95T | -3.39%4.28T | 13.21%4.21T | 42.46%2.79T | 40.52%5.15T | 41.63%4.43T |
| Staff behalf paid | 0.83%127.17B | -1.60%89.44B | 0.28%61.31B | 0.12%32.52B | 6.41%126.12B | 8.24%90.89B | 7.04%61.14B | 6.17%32.48B | 4.99%118.52B | 4.20%83.97B |
| All taxes paid | 4.07%140.88B | -9.30%107.79B | -9.35%92.67B | 17.85%75.44B | -0.39%135.37B | -0.09%118.84B | 1.91%102.23B | 334.60%64.01B | 4.52%135.9B | 2.43%118.94B |
| Net loan and advance increase | -24.19%2.05T | -19.38%1.97T | -15.28%1.61T | -12.45%1.17T | 14.04%2.7T | 20.07%2.44T | 22.03%1.9T | 42.03%1.34T | 11.56%2.37T | 17.46%2.04T |
| Net deposit in central bank and institutions | ---- | ---- | ---- | ---- | -27.05%111.36B | -12.66%106.22B | 32.82%142.4B | -0.52%110.99B | --152.66B | --121.61B |
| Net lend capital | -48.00%70.85B | ---- | -88.50%5.64B | ---- | -22.54%136.23B | -42.56%56.79B | -52.12%49.06B | -45.53%12.94B | --175.86B | --98.87B |
| Cash paid for fees and commissions | 0.54%589.65B | 3.83%473.46B | 6.17%324.13B | 12.68%184.27B | 25.00%586.48B | 26.62%456B | 31.19%305.28B | 59.13%163.54B | 21.84%469.2B | 26.42%360.14B |
| Net increase in financial assets held for trading purposes | --4.04B | --1.97B | --7.71B | 1,919.07%22.65B | ---- | ---- | ---- | -92.94%1.12B | --17.42B | --6.78B |
| Net increase in resale business funds (operating) | ---- | ---- | ---- | ---- | ---- | ---- | -34.91%370.33B | 269.60%318.9B | --490.63B | 1,443.32%566.07B |
| Cash paid relating to other operating activities | -11.52%404.45B | -8.95%332.32B | -21.04%249.11B | -20.20%161.91B | 90.82%457.13B | 74.22%364.96B | 72.79%315.49B | 36.19%202.9B | -16.64%239.57B | -25.13%209.49B |
| Special items of operating cash outflws | ---- | ---- | ---- | --368.92B | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from operating activities | -16.06%3.61T | -16.38%3.18T | -23.01%2.62T | -4.93%2.3T | 3.16%4.3T | 5.47%3.8T | 16.94%3.4T | 63.63%2.42T | 29.22%4.17T | 35.82%3.6T |
| Net cash flows from operating activities | -47.42%338.02B | 100.10%954.87B | -64.30%290.81B | -43.54%209.34B | -34.30%642.85B | -42.11%477.21B | -0.11%814.62B | -22.74%370.79B | 124.04%978.42B | 74.18%824.27B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 39.74%2.68T | 74.33%1.88T | 66.71%1.27T | 86.73%523.58B | 6.98%1.92T | -16.07%1.08T | 16.64%763.25B | -36.61%280.4B | -5.09%1.8T | -11.06%1.29T |
| Cash received from returns on investments | 12.92%302.68B | 13.40%233.58B | 18.82%157.85B | 25.42%69.53B | 6.79%268.04B | 8.06%205.97B | 10.22%132.85B | 15.60%55.44B | 6.10%251.01B | 2.62%190.61B |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 28.64%5.55B | 87.47%5.37B | 72.66%2.93B | -22.72%398M | 15.20%4.31B | -20.26%2.87B | 9.77%1.7B | 24.10%515M | 26.75%3.74B | -14.94%3.59B |
| Net cash received from disposal of subsidiaries and other business units | -41.34%1.46B | -42.77%1.28B | 223.58%1.14B | ---- | --2.48B | --2.23B | --352M | ---- | ---- | ---- |
| Cash inflows from investing activities | 36.36%2.99T | 64.44%2.12T | 59.70%1.43T | 76.46%593.51B | 7.09%2.2T | -12.82%1.29T | 15.67%898.15B | -31.46%336.35B | -3.80%2.05T | -9.52%1.48T |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 16.26%29.17B | -1.87%12.51B | 79.74%11.03B | 564.71%8.93B | 5.65%25.09B | 8.42%12.75B | -26.74%6.14B | -78.23%1.34B | 11.85%23.75B | 29.05%11.76B |
| Cash paid to acquire investments | 22.20%3.65T | 29.60%2.58T | 2.79%1.5T | 19.26%719.52B | 11.81%2.99T | -1.94%1.99T | 1.26%1.46T | -16.24%603.33B | 1.95%2.67T | 5.77%2.03T |
| Net cash paid to acquire subsidiaries and other business units | 142.73%2.74B | 363.89%2.12B | 154.93%362M | 85.19%100M | -67.02%1.13B | -78.89%457M | -92.26%142M | -96.93%54M | -31.06%3.42B | -14.16%2.17B |
| Cash outflows from investing activities | 22.20%3.69T | 29.48%2.59T | 3.12%1.52T | 20.48%728.55B | 11.66%3.02T | -1.96%2T | 0.98%1.47T | -16.96%604.73B | 1.96%2.7T | 5.85%2.04T |
| Net cash flows from investing activities | 15.66%-692.63B | 33.88%-470.81B | 85.83%-80.92B | 49.68%-135.04B | -26.02%-821.25B | -26.61%-712.08B | 15.83%-571.24B | -12.99%-268.38B | -25.67%-651.67B | -91.41%-562.42B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -77.68%765M | -62.09%494M | -98.13%23M | --5M | --3.43B | --1.3B | --1.23B | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -77.68%765M | -62.09%494M | -98.13%23M | --5M | --3.43B | --1.3B | --1.23B | ---- | ---- | ---- |
| Cash from bonds issue | 83.72%273.08B | 427.17%195.01B | 158.85%85.4B | 158.33%80B | 2.16%148.64B | -60.97%36.99B | -65.18%32.99B | 110.85%30.97B | -30.94%145.5B | -31.64%94.77B |
| Cash received from the issuance of other equity instruments | ---- | ---- | ---- | ---- | 50.00%59.99B | 50.00%59.99B | ---- | ---- | --39.99B | --39.99B |
| Cash inflows from financing activities | 29.14%273.84B | 98.92%195.51B | 149.61%85.42B | 158.35%80.01B | 14.33%212.06B | -27.07%98.28B | -63.89%34.22B | 110.85%30.97B | -12.28%185.49B | -3.33%134.76B |
| Borrowing repayment | -21.39%96.49B | 44.97%87.19B | 367.55%64.19B | 405.61%35.39B | 96.75%122.75B | 312.96%60.15B | 79.99%13.73B | 772.82%7B | -23.82%62.39B | -58.23%14.57B |
| Dividend interest payment | 6.42%136.95B | 5.70%123.29B | 39.78%9.9B | 48.67%4.41B | 8.84%128.68B | 11.41%116.64B | 130.05%7.08B | 36.54%2.97B | 13.49%118.22B | 14.56%104.69B |
| Cash payments relating to other financing activities | -4.44%7.61B | 3.75%4.87B | 6.01%3.93B | -3.22%1.63B | -0.08%7.96B | -7.25%4.69B | -5.34%3.71B | -13.68%1.68B | -13.96%7.96B | 23.17%5.06B |
| Special items of financing cash outflows | --40B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.34B | --3.34B |
| Cash outflows from financing activities | 8.35%281.04B | 18.66%215.35B | 218.21%78.02B | 255.74%41.43B | 35.16%259.38B | 42.17%181.48B | 36.54%24.52B | 136.71%11.65B | -1.75%191.91B | -2.08%127.65B |
| Net cash flows from financing activities | 84.79%-7.2B | 76.15%-19.84B | -23.73%7.4B | 99.65%38.58B | -636.61%-47.33B | -1,269.96%-83.2B | -87.37%9.7B | 97.83%19.32B | -139.85%-6.43B | -21.33%7.11B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -23.20%5.79B | -125.03%-3.89B | -63.94%5.68B | 452.39%4.06B | -57.45%7.54B | -54.65%15.54B | -13.82%15.74B | -74.66%-1.15B | 332.50%17.73B | 868.18%34.25B |
| Net increase in cash and cash equivalents | -63.17%-356.02B | 252.16%460.33B | -17.06%222.96B | -3.03%116.93B | -164.54%-218.19B | -199.78%-302.54B | 15.93%268.82B | -52.06%120.58B | 560.99%338.05B | 64.81%303.21B |
| Add:Begin period cash and cash equivalents | -19.08%925.46B | -19.08%925.46B | -19.08%925.46B | -19.08%925.46B | 41.96%1.14T | 41.96%1.14T | 41.96%1.14T | 41.96%1.14T | -8.34%805.6B | -8.34%805.6B |
| End period cash equivalent | -38.47%569.45B | 64.76%1.39T | -18.69%1.15T | -17.55%1.04T | -19.08%925.46B | -24.14%841.12B | 36.14%1.41T | 19.59%1.26T | 41.96%1.14T | 4.32%1.11T |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.